Table S6 from RNF6 Promotes Colorectal Cancer by Activating the Wnt/β-Catenin Pathway via Ubiquitination of TLE3

Lei Liu,Yanquan Zhang,Chi Chun Wong,Jingwan Zhang,Yujuan Dong,Xiangchun Li,Wei Kang,Francis K.L. Chan,Joseph J.Y. Sung,Jun Yu

DOI: https://doi.org/10.1158/0008-5472.22420406

2023-01-01

Abstract:<p>Cox regression analysis of potential poor prognostic factors for patients with colorectal cancer, (Beijing cohort 1, n=111)</p>

What problem does this paper attempt to address?

Table S4 from RNF6 Promotes Colorectal Cancer by Activating the Wnt/β-Catenin Pathway Via Ubiquitination of TLE3

Lei Liu,Yanquan Zhang,Chi Chun Wong,Jingwan Zhang,Yujuan Dong,Xiangchun Li,Wei Kang,Francis K.L. Chan,Joseph J.Y. Sung,Jun Yu

DOI: https://doi.org/10.1158/0008-5472.22420412

2023-01-01

Abstract:Cox regression analysis of potential prognostic predictors for patients in the colorectal cancer cohort (HongKong cohort 1 and BeiJing cohort 1, n=160)
Table S5 from RNF6 Promotes Colorectal Cancer by Activating the Wnt/β-Catenin Pathway via Ubiquitination of TLE3

Lei Liu,Yanquan Zhang,Chi Chun Wong,Jingwan Zhang,Yujuan Dong,Xiangchun Li,Wei Kang,Francis K.L. Chan,Joseph J.Y. Sung,Jun Yu

DOI: https://doi.org/10.1158/0008-5472.22420409

2023-01-01

Abstract:Univariate and Multivariate analysis of different prognostic parameters for patients with colorectal cancer in the Beijing cohort 2, n=148
Table S1 from RNF6 Promotes Colorectal Cancer by Activating the Wnt/β-Catenin Pathway via Ubiquitination of TLE3

Lei Liu,Yanquan Zhang,Chi Chun Wong,Jingwan Zhang,Yujuan Dong,Xiangchun Li,Wei Kang,Francis K.L. Chan,Joseph J.Y. Sung,Jun Yu

DOI: https://doi.org/10.1158/0008-5472.22420415.v1

2023-01-01

Abstract:<p>Clinicopathological features of CRC patients</p>
Figure S1 from RNF6 Promotes Colorectal Cancer by Activating the Wnt/β-Catenin Pathway via Ubiquitination of TLE3

Lei Liu,Yanquan Zhang,Chi Chun Wong,Jingwan Zhang,Yujuan Dong,Xiangchun Li,Wei Kang,Francis K.L. Chan,Joseph J.Y. Sung,Jun Yu

DOI: https://doi.org/10.1158/0008-5472.22420430.v1

2023-01-01

Abstract:RNF6 up-regulates in CRC and indicates a poor outcome of CRC patients.
Data from RNF6 Promotes Colorectal Cancer by Activating the Wnt/β-Catenin Pathway via Ubiquitination of TLE3

Lei Liu,Yanquan Zhang,Chi Chun Wong,Jingwan Zhang,Yujuan Dong,Xiangchun Li,Wei Kang,Francis K.L. Chan,Joseph J.Y. Sung,Jun Yu

DOI: https://doi.org/10.1158/0008-5472.c.6510644

2023-01-01

Abstract:AbstractGene amplification is a hallmark of cancer and is frequently observed in colorectal cancer. Previous whole-genome sequencing of colorectal cancer clinical specimens identified amplification of Ring finger protein 6 (RNF6), a RING-domain E3 ubiquitin ligase. In this study, we showed that RNF6 is upregulated in 73.5% (147/200) of patients with colorectal cancer and was positively associated with RNF6 gene amplification. Furthermore, RNF6 expression and its gene amplification were independent prognostic factors for poor outcome of patients with colorectal cancer. RNF6 promoted cell growth, cell-cycle progression, and epithelial-to-mesenchymal transition in colorectal cancer cells; RNF6 also promoted colorectal tumor growth and lung metastasis in mouse models. Mechanistic investigations revealed that RNF6 bound and ubiquitylated transducin-like enhancer of split 3 (TLE3), a transcriptional repressor of the β-catenin/TCF4 complex. RNF6-mediated degradation of TLE3 significantly suppressed the association of TLE3 with TCF4/LEF, which in turn led to recruitment of β-catenin to TCF4/LEF, triggering Wnt/β-catenin activation. Restoration of TLE3 expression abolished the oncogenic effects of RNF6. Taken together, these results demonstrate that RNF6 plays a pivotal oncogenic role in colorectal tumorigenesis.Significance: RNF6-mediated ubiquitination and degradation of TLE3 activates the Wnt/β-catenin pathway in colorectal carcinogenesis. Cancer Res; 78(8); 1958–71. ©2018 AACR.
Rnf6 Promotes Colorectal Cancer By Activating The Wnt/Beta-Catenin Pathway Via Ubiquitination Of Tle3

Lei Liu,Yanquan Zhang,Chi Chun Wong,Jingwan Zhang,Yujuan Dong,Xiangchun Li,Wei Kang,Francis K L Chan,Joseph J Y Sung,Jun Yu

DOI: https://doi.org/10.1158/0008-5472.CAN-17-2683

IF: 11.2

2018-01-01

Cancer Research

Abstract:Gene amplification is a hallmark of cancer and is frequently observed in colorectal cancer. Previous whole-genome sequencing of colorectal cancer clinical specimens identified amplification of Ring finger protein 6 (RNF6), a RING-domain E3 ubiquitin ligase. In this study, we showed that RNF6 is upregulated in 73.5% (147/200) of patients with colorectal cancer and was positively associated with RNF6 gene amplification. Furthermore, RNF6 expression and its gene amplification were independent prognostic factors for poor outcome of patients with colorectal cancer. RNF6 promoted cell growth, cell-cycle progression, and epithelial-to-mesenchymal transition in colorectal cancer cells; RNF6 also promoted colorectal tumor growth and lung metastasis in mouse models. Mechanistic investigations revealed that RNF6 bound and ubiquitylated transducin-like enhancer of split 3 (TLE3), a transcriptional repressor of the beta-catenin/TCF4 complex. RNF6-mediated degradation of TLE3 significantly suppressed the association of TLE3 with TCF4/LEF, which in turn led to recruitment of beta-catenin to TCF4/LEF, triggering Wnt/beta-catenin activation. Restoration of TLE3 expression abolished the oncogenic effects of RNF6. Taken together, these results demonstrate that RNF6 plays a pivotal oncogenic role in colorectal tumorigenesis.Significance: RNF6-mediated ubiquitination and degradation of TLE3 activates the Wnt/b-catenin pathway in colorectal carcinogenesis. (C) 2018 AACR.
Up-regulated NRIP2 in Colorectal Cancer Initiating Cells Modulates the Wnt Pathway by Targeting RORβ.

Zhenzhen Wen,Tianhui Pan,Saisai Yang,Jingwen Liu,Haiying Tao,Yiming Zhao,Dingting Xu,Wei Shao,Jia Wu,Xiyong Liu,Yongjiang Wang,Jianshan Mao,Yongliang Zhu

DOI: https://doi.org/10.1186/s12943-017-0590-2

IF: 37.3

2017-01-01

Molecular Cancer

Abstract:BACKGROUND:Colorectal cancer remains one of the most common malignant tumors worldwide. Colorectal cancer initiating cells (CCICs) are a small subpopulation responsible for malignant behaviors of colorectal cancer. Aberrant activation of the Wnt pathways regulates the self-renewal of CCIC. However, the underlying mechanism(s) remain poorly understood.METHODS:Via retroviral library screening, we identified Nuclear Receptor-Interacting Protein 2 (NRIP2) as a novel interactor of the Wnt pathway from enriched colorectal cancer colosphere cells. The expression levels of NRIP2 and retinoic acid-related orphan receptor β (RORβ) were further examined by FISH, qRT-PCR, IHC and Western blot. NRIP2 overexpressed and knockdown colorectal cancer cells were produced to study the role of NRIP2 in Wnt pathway. We also verified the binding between NRIP2 and RORβ and investigated the effect of RORβ on CCICs both in vitro and in vivo. Genechip-scanning speculated downstream target HBP1. Western blot, ChIP and luciferase reporter were carried to investigate the interaction between NRIP2, RORβ, and HBP1.RESULTS:NRIP2 was significantly up-regulated in CCICs from both cell lines and primary colorectal cancer tissues. Reinforced expression of NRIP2 increased Wnt activity, while silencing of NRIP2 attenuated Wnt activity. The transcription factor RORβ was a key target through which NRIP2 regulated Wnt pathway activity. RORβ was a transcriptional enhancer of inhibitor HBP1 of the Wnt pathway. NRIP2 prevented RORβ to bind with downstream HBP1 promoter regions and reduced the transcription of HBP1. This, in turn, attenuated the HBP1-dependent inhibition of TCF4-mediated transcription.CONCLUSIONS:NRIP2 is a novel interactor of the Wnt pathway in colorectal cancer initiating cells. interactions between NRIP2, RORβ, and HBP1 mediate a new mechanism for CCIC self-renewal via the Wnt activity.
Identification of Novel Nrf2 Target Genes As Prognostic Biomarkers in Colitis-Associated Colorectal Cancer in Nrf2-deficient Mice

Ahmed Hammad,Zhao-Hong Zheng,Yang Gao,Akhileshwar Namani,Hong-Fei Shi,Xiuwen Tang

DOI: https://doi.org/10.1016/j.lfs.2019.116968

IF: 6.78

2019-01-01

Life Sciences

Abstract:Aims: Colorectal cancer (CRC) is the third most common cancer worldwide. Nuclear factor erythroid 2-related factor 2 (Nrf2), a master regulator of many cytoprotective genes, plays a protective role in carcinogenesis. Recent studies have identified a specific gene-expression signature regulated by the Nrf2 pathway in lung adenocarcinoma and head-and-neck squamous cell cancer. However, the roles of Nrf2 in the development of colitis-associated colorectal cancer (CACC) have not been well characterized. Nrf2 target genes as prognostic biomarkers in CACC remain to be explored. Thus, this work aimed to identify the molecular changes that occur during mouse CACC progression to facilitate the development of diagnostic and prognostic biomarkers. Main methods: The CACC model was established using azoxymethane (AOM) with dextran sulfate sodium salt (DSS) in BALB/c mice for 3 weeks to induce colitis-associated adenoma (CAA, early stage) and for 9 weeks to induce colitis-associated carcinoma (CAC, late stage). Using RNA-sequencing and bioinformatics analyses we examined the mRNA expression profiles of 6 groups: wild-type control (WT-C), WT-CAA, WT-CAC, Nrf2 knockout control (Nrf2KO-C), Nrf2KO-CAA, and Nrf2KO-CAC. Key findings: In the AOM/DSS model of colitis-associated tumorigenesis, Nrf2(-/-) mice showed a phenotype similar to WT mice, but with significantly more tumors and a much higher percentage of adenocarcinomas. We identified 47 novel Nrf2 genes via gene expression profiling of tumor samples. Survival analysis showed that 23 of these genes were biomarkers of a poor prognosis in colon cancer patients. Significance: Nrf2 target genes deserve exploration as prognostic and therapeutic targets for CRC.
Supplementary Table 1 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis

Alfred S.L. Cheng,Suki S. Lau,Yangchao Chen,Yutaka Kondo,May S. Li,Hai Feng,Arthur K. Ching,Kin F. Cheung,Hoi K. Wong,Joanna H. Tong,Hongchuan Jin,Kwong W. Choy,Jun Yu,Ka F. To,Nathalie Wong,Tim H.-M. Huang,Joseph J.Y. Sung

DOI: https://doi.org/10.1158/0008-5472.22395236.v1

2023-01-01

Abstract:Supplementary Table 1 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis
Supplementary Table 7 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes Β-Catenin–dependent Hepatocarcinogenesis

Alfred S.L. Cheng,Suki S. Lau,Yangchao Chen,Yutaka Kondo,May S. Li,Hai Feng,Arthur K. Ching,Kin F. Cheung,Hoi K. Wong,Joanna H. Tong,Hongchuan Jin,Kwong W. Choy,Jun Yu,Ka F. To,Nathalie Wong,Tim H.-M. Huang,Joseph J.Y. Sung

DOI: https://doi.org/10.1158/0008-5472.22395233

2023-01-01

Abstract:Supplementary Table 7 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis
RING-finger protein 6 promotes colorectal tumorigenesis by transcriptionally activating SF3B2

Hui Xu,Chi Chun Wong,Weilin Li,Yunfei Zhou,Yan Li,Lifu Wang,Lei Liu,Jun Yu

DOI: https://doi.org/10.1038/s41388-021-01872-9

IF: 8.756

2021-10-05

Oncogene

Abstract:Abstract RNF6 is a RING finger protein with oncogenic potential. In this study, we established colon-specific RNF6 transgenic (tg) mice, and demonstrated that RNF6 overexpression accelerated colorectal carcinogenesis compared to wild-type littermates in a chemically induced colorectal cancer (CRC) model. To understand whether transcriptional activity of RNF6 underlies its oncogenic effect, we performed integrated chromatin immunoprecipitation (ChIP)-sequencing and RNA-sequencing analysis to identify splicing factor 3b subunit 2 (SF3B2) as a potential downstream target of RNF6. RNF6 binds to the SF3B2 promoter and the overexpression of RNF6 activates SF3B2 expression in CRC cells, primary CRC organoids, and RNF6 tg mice. SF3B2 knockout abrogated the tumor promoting effect of RNF6 overexpression, whereas the reexpression of SF3B2 recused cell growth and migration/invasion in RNF6 knockout cells, indicating that SF3B2 is a functional downstream target of RNF6 in CRC. Targeting of RNF6-SF3B2 axis with SF3B2 inhibitor with pladienolide B suppressed the growth of CRC cells with RNF6 overexpression in vitro and in vivo. Moreover, the combination of 5-fluorouracil (5-FU) plus pladienolide B exerted synergistic effects in CRC with high RNF6 expression, leading to tumor regression in xenograft models. These findings indicate that tumor promoting effect of RNF6 is achieved mainly via transcriptional upregulation of SF3B2, and that RNF6-SF3B2 axis is a promising target for CRC therapy.

oncology,genetics & heredity,biochemistry & molecular biology,cell biology
Gene commander in the trash heap: Transcriptional regulation and ubiquitination modification mediated by RNF6 in carcinogenesis

Min Tang,Xin Zeng,Jie Luo,Fei-Fei Quan,Chang-Ye Chen,Yu-Kun Li,Jue Liu,Qun-Feng Zhang,Fei-fei Quan,Chang-ye Chen,Yu-kun Li,Qun-feng Zhang

DOI: https://doi.org/10.1016/j.yexcr.2020.112396

IF: 4.145

2021-04-01

Experimental Cell Research

Abstract:<p>RING finger protein 6 (RNF6), a RING finger protein, has been identified as a potential tumor promoter in several cancers. However, the exact mechanism of RNF6 in cancer remains elusive. As in various diseases, RNF6 may be involved in regulating cell growth, cell proliferation, invasion, cell cycle progression, apoptosis and cell adhesion through E3 ligase-mediated ubiquitination. Thus, the research on RNF6 is mainly focused on the ubiquitination of RNF6 in recent years. This article summarizes the role of RNF6 ubiquitination in various physiological and pathological mechanisms, such as Akt/mTOR signaling pathway, Wnt/β-catenin pathway, RNF6/ERα/Bcl-xL axis, and provides knowledge and understanding for the treatment of diseases.</p>

oncology,cell biology
LINC00265 Promotes Colorectal Tumorigenesis Via ZMIZ2 and USP7-mediated Stabilization of Β-Catenin

Yahui Zhu,Li Gu,Xi Lin,Kaisa Cui,Cheng Liu,Bingjun Lu,Feng Zhou,Qiu Zhao,Hongxing Shen,Youjun Li

DOI: https://doi.org/10.1038/s41418-019-0417-3

IF: 12.067

2019-01-01

Cell Death and Differentiation

Abstract:Colorectal cancer (CRC) is the third most prevalent world cancer and oncogenic β-catenin is frequently dysregulated in CRC. Long noncoding RNAs (lncRNAs) play critical roles in colorectal tumorigenesis; however, the contributions of lncRNAs to human CRC remain largely unknown. In this study, we report that LINC00265 is upregulated and predicts poor clinical outcome in human patients with CRC. Depletion of LINC00265 and ZMIZ2 distinctly attenuates colorectal tumorigenesis in mice. Mechanistically, LINC00265 augments ZMIZ2 expression by acting as an endogenous sponge against several miRNAs, which directly target ZMIZ2 expression. Moreover, ZMIZ2 recruits the enzyme USP7, which deubiquitylates and stabilizes β-catenin, thereby facilitating colorectal tumorigenesis. In addition, β-catenin mediates LINC00265 and ZMIZ2 oncogenic phenotypes. Taken together, the LINC00265-ZMIZ2-β-catenin signaling axis plays a critical role in the colorectal tumorigenesis, which may be a potential therapeutic target.
The lncRNA NEAT1 activates Wnt/β-catenin signaling and promotes colorectal cancer progression via interacting with DDX5

Meng Zhang,Weiwei Weng,Qiongyan Zhang,Yong Wu,Shujuan Ni,Cong Tan,Midie Xu,Hui Sun,Chenchen Liu,Ping Wei,Xiang Du

DOI: https://doi.org/10.1186/s13045-018-0656-7

2018-09-05

Abstract:<h3 class="a-plus-plus">Abstract</h3> <span class="a-plus-plus abstract-section id-a-sec1"> <h3 class="a-plus-plus">Background</h3> <p class="a-plus-plus">The long noncoding RNA nuclear-enriched abundant transcript 1 (NEAT1) has been reported to be overexpressed in colorectal cancer (CRC). However, its underlying mechanisms in the progression of CRC have not been well studied.</p> </span> <span class="a-plus-plus abstract-section id-a-sec2"> <h3 class="a-plus-plus">Methods</h3> <p class="a-plus-plus">To investigate the clinical significance of NEAT1, we analyzed its expression levels in a publicly available dataset and in 71 CRC samples from Fudan University Shanghai Cancer Center. Functional assays, including the CCK8, EdU, colony formation, wound healing, and Transwell assays, were used to determine the oncogenic role of NEAT1 in human CRC progression. Furthermore, RNA pull-down, mass spectrometry, RNA immunoprecipitation, and Dual-Luciferase Reporter Assays were used to determine the mechanism of NEAT1 in CRC progression. Animal experiments were used to determine the role of NEAT1 in CRC tumorigenicity and metastasis in vivo.</p> </span> <span class="a-plus-plus abstract-section id-a-sec3"> <h3 class="a-plus-plus">Results</h3> <p class="a-plus-plus">NEAT1 expression was significantly upregulated in CRC tissues compared with its expression in normal tissues. Altered NEAT1 expression led to marked changes in proliferation, migration, and invasion of CRC cells both in vitro and in vivo. Mechanistically, we found that NEAT1 directly bound to the DDX5 protein, regulated its stability, and sequentially activated Wnt signaling. Our study showed that NEAT1 indirectly activated the Wnt/β-catenin signaling pathway via DDX5 and fulfilled its oncogenic functions in a DDX5-mediated manner. Clinically, concomitant NEAT1 and DDX5 protein levels negatively correlated with the overall survival and disease-free survival of CRC patients.</p> </span> <span class="a-plus-plus abstract-section id-a-sec4"> <h3 class="a-plus-plus">Conclusions</h3> <p class="a-plus-plus">Our findings indicated that NEAT1 activated Wnt signaling to promote colorectal cancer progression and metastasis. The NEAT1/DDX5/Wnt/β-catenin axis could be a potential therapeutic target of pharmacological strategies.</p> </span>

oncology,hematology
Reduced Frequency and Prognostic Significance of Ring Finger Protein 43 Nucleotide Polymorphisms in a Chinese Colorectal Cancer Cohort.

Dongpeng Wen,Guanghui Wang,Zhenyu Huang,Ximao Cui,Jinglue Song,Zhehui Zhu,Long Cui

DOI: https://doi.org/10.1089/dna.2019.4645

2019-01-01

DNA and Cell Biology

Abstract:The aim of this research was to verify the mutation rate of the ring finger protein 43 (RNF43) of the transmembrane E3 ubiquitin ligase and investigate the influence of single nucleotide polymorphisms (SNPs) rs2257205 in RNF43 in a Chinese colorectal cancer (CRC) cohort. DNA from 177 diagnosed CRC patients' tissues or blood samples were extracted, amplified, and sequenced. Clinicopathological features, including age, gender, tumor location, tumor-lymph node-metastasis stage, and survival information, were analyzed. Four novel RNF43 mutations (including G659 and R117 sites) were validated in 177 CRC patients; all events were somatic frameshift mutations. Furthermore, we also found that an SNP (rs2257205) of the RNF43 X117 site was associated with overall survival (OS) instead of disease-free survival. G homozygote subjects were significantly correlated with poor OS compared with another group. Then we rescued RNF43 R117R (encoded by nucleotide CGC) and R117H (encoded by nucleotide CAC) expression in the HCT116 cells and analyzed the targets of the Wnt/β-catenin pathway. The expression of CCND1 and c-Myc were decreased. The prognosis of CRC patients could be affected by the different functions of SNPs of RNF43.
Supplementary Figures from RING-Finger Protein 6 Amplification Activates JAK/STAT3 Pathway by Modifying SHP-1 Ubiquitylation and Associates with Poor Outcome in Colorectal Cancer

Qian Liang,Dan Ma,Xiaoqiang Zhu,Zhenhua Wang,Tian-Tian Sun,Chaoqin Shen,Tingting Yan,Xianglong Tian,TaChung Yu,Fangfang Guo,JiaYin Tang,Yanwei Lin,Huimin Chen,Chao Zhou,Zhizheng Ge,Ming Zhong,Jinxian Chen,Qiang Liu,Zheng Wang,Jing-Yuan Fang,Haoyan Chen,Jie Hong

DOI: https://doi.org/10.1158/1078-0432.22461033.v1

2023-01-01

Abstract:Fig. S1. RNF6 genomic amplification is prevalent in colorectal cancer and correlated with shortened patient survival. Fig. S2. RNF6 is clinically relevant in colorectal cancer. Fig. S3. Gene Ontology (GO) and Gene Set Enrichment Analysis (GSEA) in RNF6-higher/lower expression CRC cells and patients, and RNF6 is an oncogenic gene. FigureS4. RNF6 upregulates pSTAT3 via downregulating SHP-1 expression. Figure S5. RNF6 Interacts with SHP-1 and enhances ubiquitylation and degradation of SHP-1. Figure S6. Effectiveness of pSTAT3 inhibitors in treating RNF6-amplified tumors.
Elf3 Drives Β -Catenin Transactivation and Associates with Poor Prognosis in Colorectal Cancer

J-L Wang,Z-F Chen,H-M Chen,M-Y Wang,X Kong,Y-C Wang,T-T Sun,J Hong,W Zou,J Xu,J-Y Fang

DOI: https://doi.org/10.1038/cddis.2014.206

2014-01-01

Cell Death and Disease

Abstract:Aberrant regulation of the Wnt/ β -catenin pathway plays important roles in colorectal carcinogenesis, with over 90% of cases of sporadic colon cancer featuring β -catenin accumulation. While ubiquitination-mediated degradation is widely accepted as a major route for β -catenin protein turnover, little is known about the regulation of β -catenin in transcriptional level. Here we show that Elf3, a member of the E-twenty-six family of transcription factors, drives β -catenin transactivation and associates with poor survival of colorectal cancer (CRC) patients. We first found recurrent amplification and upregulation of Elf3 in CRC tissues, and further Gene Set Enrichment Analysis identified significant association between Elf3 expression and activity of WNT/ β -catenin pathway. Chromatin immunoprecipitation and electrophoretic mobility shift assay consistently revealed that Elf3 binds to and transactivates β -catenin promoter. Ectopic expression of Elf3 induces accumulation of β -catenin in both nucleus and cytoplasm, causing subsequent upregulation of several effector genes including c-Myc, VEGF, CCND1, MMP-7 and c-Jun. Suppressing Elf3 in CRC cells attenuates β -catenin signaling and decreases cell proliferation, migration and survival. Targeting Elf3 in xenograft tumors suppressed tumor progression in vivo . Taken together, our data identify Elf3 as a pivotal driver for β -catenin signaling in CRC, and highlight potential prognostic and therapeutic significance of Elf3 in CRC.
Clinical and molecular characteristics of RNF43 mutations as promising prognostic biomarkers in colorectal cancer

Zi-Yao Huang,Lei Wen,Liu-Fang Ye,Yu-Ting Lu,William Pat Fong,Ren-Jing Zhang,Si-Xian Wu,Zhi-Gang Chen,Yan-Yu Cai,Rui-Hua Xu,Yu-Hong Li,Zi-Ming Du,De-Shen Wang

DOI: https://doi.org/10.1177/17588359231220600

2024-01-01

Therapeutic Advances in Medical Oncology

Abstract:Background: Transmembrane E3 ubiquitin ligase ( RNF43) mutations are present in approximately 6–18% of colorectal cancers (CRC) and could enhance Wnt/β-catenin signaling, which is emerging as a promising therapeutic target. This study aims to investigate the clinical and molecular characteristics and potential heterogeneity of RNF43-mutant CRC. Methods: A total of 78 patients with RNF43-mutant CRC were enrolled from July 2013 to November 2022. Demographic data, clinical characteristics, treatment regimens used, and survival outcomes were collected and analyzed. Results: Our study uncovered that patients with RNF43 mutations in the N-terminal domain (NTD; n = 50) exhibited shorter overall survival (OS; median months, 50.80 versus not reached; p = 0.043) compared to those in the C-terminal domain (CTD; n = 17). Most RNF43 mutations in NTD had positive primary lymph node status, low tumor mutation burden (TMB-L), and correlated with proficient mismatch repair (pMMR)/microsatellite stable (MSS) status. By contrast, RNF43 mutations in CTD were significantly enriched in deficient MMR (dMMR)/microsatellite instability (MSI-H) tumors with high TMB (TMB-H). N-terminal RNF43-mutated tumors harbored a hotspot variant ( RNF43 R117fs), which independently predicted a significantly worse outcome in pMMR/MSS CRC with a median OS of 18.9 months. Patients with RNF43 mutations and the BRAF V600E alterations demonstrated sensitivity to BRAF/EGFR inhibitors. Moreover, we observed that pMMR/MSS patients with RNF43 R117fs mutation had a higher incidence of stage IV, ⩾2 metastatic sites, low TMB, and none of them received PD-1/PD-L1 inhibitor therapy. Conclusion: Our findings provide the first evidence that RNF43 mutations in NTD and the R117fs variant correlate with a poorer prognosis in CRC patients, providing strategies for Wnt-targeted therapy to improve clinical efficacy.

oncology
RNF186/EPHB2 Axis is Essential in Regulating TNF Signaling for Colorectal Tumorigenesis in Colorectal Epithelial Cells

Huazhi Zhang,Zhihui Cui,Ting Pan,Huijun Hu,Ruirui He,Ming Yi,Wanwei Sun,Ru Gao,Heping Wang,Xiaojian Ma,Qianwen Peng,Xiong Feng,Shuyan Liang,Yanyun Du,Chenhui Wang

DOI: https://doi.org/10.4049/jimmunol.2200229

2022-01-01

The Journal of Immunology

Abstract:The receptor tyrosine kinase EPHB2 (EPH receptor B2) is highly expressed in many human cancer types, especially in gastrointestinal cancers, such as colorectal cancer. Several coding mutations of the EPHB2 gene have been identified in many cancer types, suggesting that EPHB2 plays a critical role in carcinogenesis. However, the exact functional mechanism of EPHB2 in carcinogenesis remains unknown. In this study, we find that EPHB2 is required for TNF-induced signaling activation and proinflammatory cytokine production in colorectal epithelial cells. Mechanistically, after TNF stimulation, EPHB2 is ubiquitinated by its E3 ligase RNF186. Then, ubiquitinated EPHB2 recruits and further phosphorylates TAB2 at nine tyrosine sites, which is a critical step for the binding between TAB2 and TAK1. Due to defects in TNF signaling in RNF186-knockout colorectal epithelial cells, the phenotype of colitis-propelled colorectal cancer model in RNF186-knockout mice is significantly reduced compared with that in wild-type control mice. Moreover, we find that a genetic mutation in EPHB2 identified in a family with colorectal cancer is a gain-of-function mutation that promoted TNF signaling activation compared with wild-type EPHB2. We provide evidence that the EPHB2-RNF186-TAB2-TAK1 signaling cascade plays an essential role in TNF-mediated signal transduction in colorectal epithelial cells and the carcinogenesis of colorectal cancer, which may provide potential targets for the treatment of colorectal cancer.

Table S6 from RNF6 Promotes Colorectal Cancer by Activating the Wnt/β-Catenin Pathway via Ubiquitination of TLE3

Table S4 from RNF6 Promotes Colorectal Cancer by Activating the Wnt/β-Catenin Pathway Via Ubiquitination of TLE3

Table S5 from RNF6 Promotes Colorectal Cancer by Activating the Wnt/β-Catenin Pathway via Ubiquitination of TLE3

Table S1 from RNF6 Promotes Colorectal Cancer by Activating the Wnt/β-Catenin Pathway via Ubiquitination of TLE3

Figure S1 from RNF6 Promotes Colorectal Cancer by Activating the Wnt/β-Catenin Pathway via Ubiquitination of TLE3

Data from RNF6 Promotes Colorectal Cancer by Activating the Wnt/β-Catenin Pathway via Ubiquitination of TLE3

Rnf6 Promotes Colorectal Cancer By Activating The Wnt/Beta-Catenin Pathway Via Ubiquitination Of Tle3

Up-regulated NRIP2 in Colorectal Cancer Initiating Cells Modulates the Wnt Pathway by Targeting RORβ.

Identification of Novel Nrf2 Target Genes As Prognostic Biomarkers in Colitis-Associated Colorectal Cancer in Nrf2-deficient Mice

Supplementary Table 1 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis

Supplementary Table 7 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes Β-Catenin–dependent Hepatocarcinogenesis

RING-finger protein 6 promotes colorectal tumorigenesis by transcriptionally activating SF3B2

Gene commander in the trash heap: Transcriptional regulation and ubiquitination modification mediated by RNF6 in carcinogenesis

LINC00265 Promotes Colorectal Tumorigenesis Via ZMIZ2 and USP7-mediated Stabilization of Β-Catenin

The lncRNA NEAT1 activates Wnt/β-catenin signaling and promotes colorectal cancer progression via interacting with DDX5

Reduced Frequency and Prognostic Significance of Ring Finger Protein 43 Nucleotide Polymorphisms in a Chinese Colorectal Cancer Cohort.

Supplementary Figures from RING-Finger Protein 6 Amplification Activates JAK/STAT3 Pathway by Modifying SHP-1 Ubiquitylation and Associates with Poor Outcome in Colorectal Cancer

Elf3 Drives Β -Catenin Transactivation and Associates with Poor Prognosis in Colorectal Cancer

Clinical and molecular characteristics of RNF43 mutations as promising prognostic biomarkers in colorectal cancer

RNF186/EPHB2 Axis is Essential in Regulating TNF Signaling for Colorectal Tumorigenesis in Colorectal Epithelial Cells